Overall rank by patents
#34,165
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, active 2022–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06F (ELECTRIC DIGITAL DATA PROCESSING).
The verdict
Applica holds 7 US patents across 4 technology areas, rank #34,165 of 50,000 tracked assignees.
Applica SP. Z O.o. has been granted 7 US utility patents between 2022 and 2024, placing Applica SP. Z O.o. at rank #34,165 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 28.0 claims per patent with primary concentration in G06F (ELECTRIC DIGITAL DATA PROCESSING). As a Foreign Corporation, Applica SP. Z O.o. is one of the more focused assignees in the PatentsView dataset. By volume, Applica sits between Apirx Pharmaceutical USA, Llc (7 patents, rank #34,161) and Appotronics China Corporation (7 patents, rank #34,169) - the closest US assignees by grant volume. The composite Innovation Score of 49.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2024, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Applica SP. Z O.o.'s 28.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Applica SP. Z O.o. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
APIRx Pharmaceutical USA, LLC
7 patents
APL TECHNOLOGY AS
7 patents
APOLLO PRECISION KUNMING YUANHONG LIMITED
7 patents
APOS—Medical and Sports Technologies Ltd.
7 patents
APPLICATIONS MOBILES OVERVIEW INC.
7 patents
APPLIED GRAPHENE MATERIALS UK LIMITED
7 patents
APPLIED RECOGNITION CORP.
7 patents
APPOTRONICS CHINA CORPORATION
7 patents
APPLICA SP. Z O.O.
7 patents
What this shows Applica holds 7 patents at rank #34,165, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #34,165 in granted patent volume.
Other assignees with the most granted patents in Applica's primary technology class.
Applica's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 15% higher than 85% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 1 | 14.3% |
| 2023 | 2 | 28.6% |
| 2024 | 4 | 57.1% |
Top 4 of 4 technology areas
Overall rank by patents
#34,165
Across all tracked assignees
49.3 out of 100
How to use this portfolio
Applica's 7 grants land it in the top 15% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.